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abstract
Background: Oral candidosis is an infection caused by mainly Candida albicans. Candida species are common normal flora in	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
the	oral	cavity	and	have	been	reported	to	be	present	in	40%	to	60%	of	the	population.	Candida	is	predominantly	an	opportunistic	
infectious	agent.	Infection	frequency	has	increased	because	of	the	presence	of	both	local	and	systemic	risk	factors.	The	elderly	age	
and	diabetes	mellitus	may	decrease	the	amount	of	saliva	(xerostomia)	and	potentially	increase	the	risk	of	colonization	and	secondary	
infection	by	Candida.	Herpes	Zoster	(HZ)	is	a	manifestation	of	the	reactivation	of	latent	varicella	zoster	virus.	It	is	characterized	by	
unilateral,	painful,	vesicular	rash	with	a	dermatomal	distribution.	The	clinical	manifestations	of	this	disease	can	erupt	to	the	skin	
and	mucous	membrane.	If	maxillary	nerve	is	involved,	the	lesion	can	appear	on	unilateral	facial	skin	and	oral	mucous	membrane.	
Purpose: The purpose of this paper is to report and discuss the difficulties in managing the oral candidosis in elderly patient (57	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
year	old	male)	who	suffered	from	maxillary	Herpes	Zoster	and	diabetes	mellitus.	Case management: At first, the patient was treated	 	 	 	 	 	 	
with	2%	chlorhexidine	gluconate	and	mycostatin	oral	suspension	as	topical	antimycotic	and	reffered	to	dermathology	clinic	for	viral	
infection	 treatment,	however	 the	oral	candidosis	did	not	 improved.	Subsequently,	ketokonazole	 tablet	was	given	 three	 times	daily	
for	three	weeks	and	regulated	blood	glucose	level.	In	systemic	antifungi	(ketokonazole)	treatment	the	oral	candidosis	disappeared.	
Conclusion: In this case, it is conclude that the management of oral candidosis are adequate, antiviral, blood glucose level regulating	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
and	systemic	antifungal	therapy.	
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introduction
Candida is a yeast-like fungus. Candida species are 
common in the normal flora and have been reported to be 
present in 40% to 60% of the population.1 It is harmless, but 
it might become opportunistic pathogen when there is oral 
immune decreasing as a result of the oral microorganism 
ecosystem changes. Candidosis is an infection caused 
by Candida, mainly C.	albicans. Infection frequency by 
Candida species has increased because of the presence 
of both local and systemic risk factors. The systemic 
risk factors are treatment with broad spectrum antibiotic, 
diabetes mellitus and immunosuppressive illness.1,2
The symptoms of candidosis may include burning 
sensation, sensitivity, altered taste and smell. Clinical 
intra oral sign may vary from a red form (erythematous) to 
psedomembranous form (white, thrush); simultaneous red 
and white changes are common. Oral candidal overgrowth 
is almost superficial and rarely penetrates deeper than 
epithelial cells surfaces. The pseudomembranous form is 
the colonies of organisms that attach to the surface and 
can be removed with rubbing, frequently leaving red or 
bleeding sites.1
Varicella Zoster Virus (VZV) is DNA virus that causes 
chicken pox in children as primary infection and herpes 
zoster (shingles) in adult as subsequent reactivation. This 
disease can affect the skin and oral mucous membrane. 
Chicken pox is caused by droplet infection or direct 
contact with patient, usually benign illness that occurs in 
epidemic among susceptible children. Although, the clinical 
Case Report
133Kamadjaja and Pramono: Management of zygomatic-maxillary fracture
symptom on skin or mucous membrane disappear, zoster 
virus still resides in dorsal-root ganglia and subsequent 
reactivation can occur.3,4 Virus reactivation does not always 
give the clinical symptoms, because virus-cell mediated 
immunity can protect the host. The risk of shingle is 
increased by declining cell mediated immune responses, 
which occur naturally as a result of aging or induced by 
immunosuppressive illness or medical treatments.3,5
At an incidence of 2/1000, about 500,000 cases annually 
would occur in the United States and about half this number 
in the United Kingdom. The incidence rises steeply with 
age, being less than 1 per 1000 person years in children 
and as many as 12 per 1000 person years in those over 65 
years old.5 Seventy percent of herpes zoster occurred on 
persons over 50 year old.4
The initial symptoms are pain and tenderness in the 
affected area and prodromal severe pain of herpes zoster. 
Characteristic of herpes zoster are multiple vesicles, which 
distributed in appropriate sensory nerve region. When 
the maxillary nerve is involved, the lesion can appear on 
unilateral facial skin and oral mucous membrane, this is 
about 15% of the cases.4 The patient suffers from tooth-ache 
in the nerve region which is involved and frequently it can 
not be distinguished with trigeminal zoster.3,6 
When this disease is not treated, vesicles on skin and 
ulcers in oral mucous membrane will disappear in 2-4 
weeks or more. Crusts appears on the skin and might form 
scarring. Although there are several serious complications 
of zoster (ophthalmic, splanchnic, cerebral motor), in 
immunocompromise adult the most common case is 
post herpetic neuralgia- pain. Postherpetic neuralgia is a 
condition in which the patient suffers from anesthesia, 
paraesthesia and severe pain in the involved nerve region. 
The pain sensation is still persisted for prolong time until 
years after clinical sign disappears. Both the incidence and 
the duration of postherpetic neuralgia are directly correlated 
with the patient’s age.3,4,5 
This article reported a case of oral candidosis on herpes 
zoster which involved the maxillary nerve. The patient was 
57 years old and also suffered from diabetes mellitus.
case 
In October 17, 2006, a 57 years old male came to the 
dental clinic at Dr. Soetomo General Hospital Surabaya, 
the patient complained of severe left tooth-ache in 5 days. 
Initially, the patient came to the public medical center 
for treating his teeth, but the pain didn’t reduce although 
the teeth was already filled, even the left facial skin was 
oedem and erythemathous, followed by fever, malaise and 
weakness. Then, the patient went to general practitioner and 
was treated with antibiotic and analgesic/anti-inflammation. 
The patient still suffered from severe teeth-ache on the 
maxillary left-region. Formerly, the patient suffered from 
localized abnormal skin sensations, ranging from itching 
or tingling on the left facial-skin and followed by the 
appearance of clusters of clear vesicles.
Extra oral examination showed pustulation, ulceration, 
crusting and oedema on the left facial skin (Figure 1). 
Several lesions on the left lower lid caused lid edema 
and ectropion, involved left nose and upper lip. Left 
submandibular lymph nodes were enlarged and tender. On 
intra oral examination (Figure 2 & 3), white plaque was 
revealed on hard palate, thick and soft as creamy milk with 
irregular border and form, surrounded by erythemathous and 
can be removed with rubbing. Erythemathous and multiple 
ulcers with 2-4mm diameter were found on maxillary left 
buccal-fold and left buccal mucosa, the center of ulcers 
were yellowish and painful. Erythemathous mucosa and 
white thin-plaque, irregular form and scrapable were found 
on the left upper lip.
case management
The patient previously came to the public medical center 
with chief complaint left upper teeth-ache. In fact, the 
figure 1. First visit: Extra oral view.
figure 2. First visit: Intra oral view. 
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figure 3. First visit: Palatal view. 
lesions on the skin had emerged but the patient neglected 
and only focused on his tooth-ache. 
In the dental clinic, the patient was treated with 
benzidamine-HCl rinse 4 times daily and multivitamin plus 
Zn one caplet daily. Because of weak general condition 
and chief complaint of severe pain on the facial skin, the 
patient referred to dermatology clinic and had to control 
a week later.
Control first (October 30, 2006): According to the 
anamnesis, the patient said that he had been hospitalized 
for 4 days in dermatology clinic and given erythromycin 
3 × 500 mg/daily, acyclovir 5 × 800 mg/daily, amytriptilin 
2 × 25 mg/daily, mefenamic acid 3 × 1/daily, bioneuron 
1 × 1/daily and eye drops and skin ointment. The patient 
suffered from severe pain, liked tingling sensation on 
the left-facial skin, with pain-duration about 15 seconds 
continually almost everyday. Extra oral examination 
showed left submandibular lymph nodes were enlarged, 
springy and pain. Dark brown-crusting surrounded by 
erythemathous on left facial skin, and desquamation 
followed yellowish by crusting on upper lips. Intra oral 
examination showed that ulcers and erythemathous on the 
left buccal mucosa and buccal-fold disappeared, but white 
plaque on the left palate still persisted. Chlorhexidine 
gluconate 0, 2% oral rinse and multivitamin plus Zn caplet 
one daily were administered.
Control second (November 07, 2006): Pain sensation 
on the left facial skin and teeth-ache still persisted, as well 
as the left ear region although aulin tablet had been given. 
Left submandibular lymph nodes did not change, left facial 
skin revealed hyper-pigmentation. White plaque on the left 
palate was thinner and difficult to be scraped (Figure 4). 
Oral rinse and multivitamin plus Zn caplet were repeated 
and mycostatin oral suspention was added. Therefore, the 
patient referred to mycological laboratory and ENT (Ear 
Nose Throat) clinic.
Control third (November 14, 2006): Pain sensation 
on the left ear had gone, but still existed on the facial 
skin and teeth. Left submandibular lymph nodes were 
normal; hyperpigmention on the facial skin was thinner. 
White plaque on the left palate changed to be smaller 
and thinner, left upper teeth region were unstable grade 
three. Radiographic examination showed the resorbtion 
of alveolar bone. This data supported that the patient has 
diabetes mellitus. 
Mycological finding showed positive Candida infection, 
therefore final diagnosis on the palatum was oral candidosis 
(thrush). The mycostatin oral suspension and chlorhexidine 
gluconate 0.2% oral rinse treatment was continued. In 
fact, the third control (four weeks later) showed that oral 
candidosis did not change; therefore the patient was given 
ketokonazole tablets three times daily. Then, the patient was 
referred to clinic of diabetes mellitus and neurology.
Control fourth (November 21, 2006): From neurology 
clinic, the patient was given amitriptilyn, carbamazepin, 
neurobion and pondex, that were regularly taken for 
reducing pain. Actually, pain sensation on the left facial 
skin and left upper teeth region were reduced, but the patient 
complained of xerostomia.
 Hyperpigmentation on the left facial skin still existed 
although it was thinner. White plaque on left palate was 
smaller and slighter, on upper and lower buccal mucosa 
were painful. There was white plaque on dorsal tongue, 
thick and scrapable, surrounded by erythematous. Oral rinse 
was repeated and ketokonazole tablet was continued.
Control fifth (November 28, 2006): Laboratory result 
(November 23, 2006) showed that fasting blood glucose 
level was 109mg/dl and 2 hours postprandial was 162mg/dl, 
it proved that the patient suffered from diabetes mellitus. 
According to the anamnesis, 5 days before control the 
patient got spontaneous loss of two of the upper left teeth 
(canine and first premolar). 
Extra oral and intra oral examination showed that 
hyperpigmentation of the left facial skin was thinner and 
sometime less pain sensation (Figure 5 and 6). The upper lip 
was dry, desquamative and fissured. Dry socket was found 
in the region of post spontaneous teeth loss. White plaque on 
figure 4.  Third visit: White plaque on the left palate was thinner 
and difficult to be scraped
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the left palate disappeared, but on the dorsum of the tongue 
still existed. Therefore, ketokonazole tablet was repeated, 
and vitamin C tablet as supporting treatment, mefenamic 
acid and benzidamine HCl oral rinse for reducing pain 
was added and alvogyl fibre was topically given in the dry 
socket region. The patient was referred to diabetes clinic 
for blood regulation controlling. If the blood regulation 
was normal, the left upper teeth which unstable grade three 
would be extracted. 
Control sixth (December 05, 2006): Although the 
patient was given medicines for diabetes mellitus, the blood 
glucose level was still higher than normal, consequently the 
patient’s pain-labile-teeth could not be extracted, therefore 
the patient had to wait for normal condition. The brown-
macula presented on the left facial skin and there was no 
pain sensation, thinner white plaque was presented on the 
dorsum of the tongue. Ketokonazole tablets was continued, 
and the patient was given vitamin C and B complex tablets 
for supporting treatment. The patient suggested to control 
one month later.
Control seventh (January 9, 2007): A week before 
control, the patient got spontaneous loss of the front of the 
upper teeth (left second incisor). The brown macula on 
the left facial skin was thinner, and intra oral examination 
showed white plaque disappeared. The fasting blood 
glucose level was 78 mg/dl and 2 hours postprandial 
blood glucose level was 136mg/dl, it indicated the normal 
condition was reached. Then, the patient referred to oral 
surgery clinic for extracting of the front upper teeth which 
unstable grade three (the left upper central incisor and 
canine). Blood glucose level decreasing would improve 
the patient’s general condition.
discussion 
Base on the general condition, anamnesis and extra oral 
examination, the clinical diagnosis of this case was herpes 
zoster which involved trigeminal nerve. The appearance 
of herpes zoster is sufficiently distinctive that a clinical 
diagnosis is usually accurate.7 This case involved left facial 
skin and limited on the left lower lid caused lid edema and 
ectropion, involved left nose and upper lip. The present 
unilateral ulceration or skin lesions limited in area supplied 
by one division of the trigeminal nerve suggests a diagnosis 
of zoster.3 
The maxillary division of the trigeminal nerve is entirely 
sensory, supplying the skin of the middle portion of the 
face, lower eyelids, side of the nose, upper lip, mucous 
membranes of the nasopharynx, maxillary sinus, soft 
palate, and teeth. Near its origin it branches off to form 
the middle meningeal nerve, which supplies the ipsilateral 
middle meningeal artery and branches to durameter. One 
of its terminal branches is the greater palatine nerve, 
which supplies the hard palate, a portion of the maxillary 
gingival, the uvula, and a portion of the soft palate. The 
other important branch is the superior alveolar nerve, 
which supplies the maxillary gingival, teeth, and mucous 
membranes of the cheek.8
If the maxillary or mandibulary division of the 
trigeminal nerve were involved, the patient may experience 
toothache-like pain for several days prior to the onset of 
more characteristic cutaneous lesions.7 The patient suffers 
from tooth-ache in the nerve region which is involved 
and frequently can not be distinguished with trigeminal 
zoster.3,6 
On intra oral examination, erythemathous and multiple 
ulcers were found on maxillary left buccal-fold mucosa, left 
buccal and upper lip mucosa, uvula and left soft palate. On 
left hard palate there was white plaque, thick and soft as 
figure 5.  Post treatment: extra oral view. 
figure 6.  Post treatment: intra oral view.
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creamy milk, irregular border and form, can be removed 
with rubbing and surrounded by erythemathous. Based on 
intra oral examination, trigeminal nerve which involved in 
this case was maxillary division. 
Thrush as secondary infection was suspected on the 
left hard palate and upper lip mucosa. It occurred because 
the patient took antibiotic from private physician and there 
were multiple ulcers caused by maxillary herpes zoster 
infection.
Acyclovir 800 mg five times daily will inhibit the 
replication of varicella zoster virus by shortening the 
duration of viral shedding, halting the formation of new 
lesions more quickly, accelerating the rate of healing, and 
reducing the severity of acute pain. Attenuation to the 
severity of the acute infection and the neural damage will 
reduce the likelihood of post herpetic neuralgia.3,5 The pain 
of post herpetic neuralgia can be reduced by a number of 
medications. Tricyclic antidepressant medications such as 
amitriptyline (Elavil), as well as anti-seizure medications 
such as gabapentin (Neurontin) and carbamazipine 
(Tegretol), have been used to relieve the pain associated 
with herpetic neuralgia. Finally, capsaicin cream (Zostrix), 
a derivative of hot chili peppers, can be used topically on the 
area after all the blisters have healed, to reduce the pain.9
Until the 13th days, the patient still suffered from 
severe pain on the left facial skin although a number of 
medications was given to reduce pain. It proved that, the 
patient suffered acute herpetic neuralgia. According to 
Johnson and Dworkin,5 acute herpetic neuralgia defines 
as pain within 30 days from rash onset. 
At the second control, white plaque at he left palate was 
thinner but difficult to be scrapped, therefore chlorhexidine 
gluconate 2% (and multivitamin plus Zn caplet) were 
repeated and mycostatin oral suspension as antimycotic 
topical was added.
Intra oral examination at the third control revealed 
that left upper teeth region were unstable grade three. 
Radiographic examination showed resorbtion of alveolar 
bone. This data supported that the patient suffered from 
diabetes mellitus. Mycological finding showed positive 
Candida infection, thus final diagnosis on the palatum 
was oral candidosis (thrush). Antimycotic topical was 
continued and the patient was given antimycotic systemic 
(ketokonazole tablets three times daily). 
 Laboratory finding (November 23, 2006) showed that 
fasting blood glucose level was 109 mg/dl and 2 hours 
postprandial was 162 mg/dl, it is really proved that the 
patient suffered from diabetes mellitus. Diabetes mellitus 
on this patient is caused by poor condition, xerostomia, 
leading to unstable upper left-teeth on the third degree 
and followed by spontaneous loss of teeth. This disease 
also caused oral candidosis which was difficult to treat. 
Blood glucose level decreasing would improve the patient’s 
general condition.
Since the patient not only suffered from herpes zoster 
in the maxillary nerve but also oral candidosis and diabetes 
mellitus, he was classified as immunocompromised patient. 
Oral candidosis of immuno-compromised patients should 
be treated with systemic antifungals.10 
The involvement of oral candidosis, herpes zoster virus 
infection and diabetes mellitus, made this case complicated 
and multidisciplinary approached is needed. It is concluded 
that the management of in this case, it oral candidosis are 
adequate antiviral, blood glucose level regulating and 
systemic antifungal therapy.	
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